138 related articles for article (PubMed ID: 9116178)
1. Decreased lumbar cerebrospinal fluid levels of monoamine metabolites in vascular dementia.
Wallin A; Blennow K; Edman A; Månsson JE
Int Psychogeriatr; 1996; 8(3):425-36. PubMed ID: 9116178
[TBL] [Abstract][Full Text] [Related]
2. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.
Blennow K; Wallin A; Gottfries CG; Lekman A; Karlsson I; Skoog I; Svennerholm L
Neurobiol Aging; 1992; 13(1):107-13. PubMed ID: 1371850
[TBL] [Abstract][Full Text] [Related]
3. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid.
Blennow K; Wallin A; Gottfries CG; Månsson JE; Svennerholm L
J Neural Transm Park Dis Dement Sect; 1993; 5(1):5-15. PubMed ID: 7679905
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age.
Blennow K; Wallin A; Gottfries CG; Karlsson I; Månsson JE; Skoog I; Wikkelsö C; Svennerholm L
Eur Neuropsychopharmacol; 1993 Mar; 3(1):55-61. PubMed ID: 7682460
[TBL] [Abstract][Full Text] [Related]
5. CSF monoamine metabolites in old age dementias.
Parnetti L; Gaiti A; Reboldi GP; Santucci C; Mecocci P; Brunetti M; Cadini D; Senin U
Mol Chem Neuropathol; 1992; 16(1-2):143-57. PubMed ID: 1381590
[TBL] [Abstract][Full Text] [Related]
6. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
von Holst H; Lindquist C; Sedvall G
Acta Neurochir (Wien); 1985; 77(3-4):146-51. PubMed ID: 2416192
[TBL] [Abstract][Full Text] [Related]
7. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
[TBL] [Abstract][Full Text] [Related]
8. Gradients of CSF monoamine metabolites: a comparison between male and female volunteers.
Nordin C; Eklundh T; Fernström V; Swedin A; Zachau AC
J Psychiatr Res; 1995; 29(2):133-40. PubMed ID: 7545235
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
[TBL] [Abstract][Full Text] [Related]
10. Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.
Bråne G; Gottfries CG; Blennow K; Karlsson I; Lekman A; Parnetti L; Svennerholm L; Wallin A
Alzheimer Dis Assoc Disord; 1989; 3(3):148-56. PubMed ID: 2477044
[TBL] [Abstract][Full Text] [Related]
11. Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers.
Alfredsson G; Wiesel FA; Tylec A
Biol Psychiatry; 1988 Apr; 23(7):689-97. PubMed ID: 2453224
[TBL] [Abstract][Full Text] [Related]
12. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
13. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Yoshino K
No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
[TBL] [Abstract][Full Text] [Related]
14. Monoamine metabolites in the CSF of epileptic patients.
Laxer KD; Sourkes TL; Fang TY; Young SN; Gauthier SG; Missala K
Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460
[TBL] [Abstract][Full Text] [Related]
15. Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects.
Hagenfeldt L; Bjerkenstedt L; Edman G; Sedvall G; Wiesel FA
J Neurochem; 1984 Mar; 42(3):833-7. PubMed ID: 6198473
[TBL] [Abstract][Full Text] [Related]
16. Effects of idebenone on monoamine metabolites in cerebrospinal fluid of patients with cerebrovascular dementia.
Kawakami M; Itoh T
Arch Gerontol Geriatr; 1989 May; 8(3):343-53. PubMed ID: 2475076
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid.
Hildebrand J; Bourgeois F; Buyse M; Przedborski S; Goldman S
Acta Neurol Scand; 1990 May; 81(5):427-30. PubMed ID: 1695809
[TBL] [Abstract][Full Text] [Related]
18. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
Davidson D; Pullar IA; Mawdsley C; Kinloch N; Yates CM
J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):741-5. PubMed ID: 925693
[TBL] [Abstract][Full Text] [Related]
19. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
Sjöström R; Ekstedt J; Anggård E
J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
[TBL] [Abstract][Full Text] [Related]
20. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis.
Andersen O; Johansson BB; Svennerholm L
Acta Neurol Scand; 1981 Apr; 63(4):247-54. PubMed ID: 6163303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
